我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

光学相干断层成像技术在冠状动脉介入诊疗中的应用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第5期
页码:
594-599
栏目:
综述
出版日期:
2018-06-25

文章信息/Info

Title:
Application of optical coherence tomography in coronary intervention
作者:
邓龙祥; 刘 毅; 袁 铭
(第四军医大学西京医院心血管内科，陕西 西安 710032)
Author(s):
DENG Long-xiang;  LIU Yi;  YUAN Ming
(Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
光学相干断层成像技术; 冠状动脉疾病; 经皮冠状动脉介入治疗
Keywords:
optical coherence tomography;  coronary artery disease;  percutaneous coronary Intervention
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
随着经皮冠状动脉介入（PCI）技术的不断发展，血管内成像技术在冠状动脉疾病临床诊疗中正发挥日益重要的作用。光学相干断层成像技术（OCT）作为新一代血管内成像技术，它可以提供更高分辨率的图像以及接近显微水平的斑块特性，支架内再狭窄，血栓特征等细节，而这又决定它可以更好地预测急性冠脉综合症的发生以及更准确的识别其病因。目前，有研究表明OCT对PCI手术的优化及对支架内皮化、新生内膜增生的评价可以改善及预判临床预后，相信随着OCT技术的进一步发展，它在冠状动脉疾病临床诊疗中的应用的广度及深度将会显著增加，将发挥越来越重要的作用。
Abstract:
With the development of percutaneous coronary intervention, intravascular imaging has played an increasingly important role in the clinical diagnosis and treatment of coronary artery disease. Optical coherence tomography (OCT), is a new generation of intravascular imaging technology, and can provide higher resolution images and near microscopic details of plaques, stent restenosis and thrombus characteristics. OTC can better predict acute coronary syndrome and identify its etiology. At present, studies have shown that the optimization of PCI and evaluation of stent endothelialization and neointimal hyperplasia using OCT can improve and predict clinical prognosis. It is believed that with further development of OCT technology, its breadth and depth in the clinical diagnosis and treatment of coronary artery disease will be significantly increased and OTC will thus play an increasingly important role in the clinical diagnosis and treatment of coronary artery disease.

参考文献/References

[1]Huang D,Swanson EA,Lin CP,et al.Optical coherence tomography[J].Science,1991,254(5035):1178-1181.

[2]Jang IK,Tearney G,Bouma B.Visualization of tissue prolapse between coronary stent struts by optical coherence tomography:comparison with intravascular ultrasound[J].Circulation,2001,104(22):2754.

[3]Terashima M,Kaneda H,Suzuki T.The Role of Optical Coherence Tomography in Coronary Intervention[J].Korean J Intern Med,2012,27(1):1.

[4]Bezerra HG,Attizzani GF,Sirbu V,et al.Optical Coherence Tomography Versus Intravascular Ultrasound to Evaluate Coronary Artery Disease and Percutaneous Coronary Intervention[J].JACC Cardiovasc Interv,2013,6(3):228-236.

[5]Stone GW,Maehara A,Lansky AJ,et al.A prospective natural-history study of coronary atherosclerosis[J].N Engl J Med,2011,364(3):226-235.

[6]Yun KH,Mintz GS,Farhat N,et al.Relation between angiographic lesion severity,vulnerable plaque morphology and future adverse cardiac events(from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study)[J].Am J Cardiol,2012,110(4):471-477.

[7]Cheng JM,Garcia-Garcia HM,de Boer SP,et al.In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome:results of the ATHEROREMO-IVUS study[J].Eur Heart J,2014,35(10):639-647.

[8] Prati F,Regar E,Mintz GS,et al.Expert review document on methodology,terminology, and clinical applications of optical coherence tomography:physical principles,methodology of image acquisition,and clinical application for assessment of coronary arteries and atherosclerosis[J].Eur Heart J,2010,31(4):401-415.

[9]Tearney GJ,Regar E,Akasaka T,et al.Consensus standards for acquisition,measurement,and reporting of intravascular optical coherence tomography studies:a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation[J].J Am Coll Cardiol,2012,59(12):1058-1072.

[10]Finn AV,Nakano M,Narula J,et al.Concept of vulnerable/unstable plaque[J].Arterioscler Thromb Vasc Biol,2010,30(7):1282-1292.

[11]Radu MD,Yamaji K,Garcia-Garcia HM,et al.Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment[J].EuroIntervention,2016,12(8):e987-e997.

[12]Kume T,Akasaka T,Kawamoto T,et al.Measurement of the thickness of the fibrous cap by optical coherence tomography[J].Am Heart J,2006,152(4):751-755.

[13]Kume T,Okura H,Yamada R,et al.Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: an ex vivo validation and an initial in vivo feasibility study[J].Circ J,2009,73(6):1086-1091.

[14]Yabushita H,Bouma BE,Houser SL,et al.Characterization of human atherosclerosis by optical coherence tomography[J].Circulation,2002,106(13):1640-1645.

[15]Kawasaki M,Bouma BE,Bressner J,et al.Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques[J].J Am Coll Cardiol,2006,48(1):81-88.

[16]Karanasos A,Ligthart JM,Witberg KT,et al.Calcified nodules:an underrated mechanism of coronary thrombosis?[J].JACC Cardiovasc Imaging,2012,5(10):1071-1072.

[17]Hao H,Fujii K,Shibuya M,et al.Different findings in a calcified nodule between histology and intravascular imaging such as intravascular ultrasound, optical coherence tomography, and coronary angioscopy[J].JACC Cardiovasc Interv,2014,7(8):937-938.

[18]Macneill BD,Jang IK,Bouma BE,et al.Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease[J].J Am Coll Cardiol,2004,44(5):972-979.

[19]de Gaetano M,Crean D,Barry M,et al.M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis[J].Front Immunol,2016,7:275.

[20]Kim JB,Park K,Ryu J,et al.Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors[J].Sci Rep,2016,6:22608.

[21]Kubo T,Imanishi T,Takarada S,et al.Assessment of culprit lesion morphology in acute myocardial infarction:ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy[J].J Am Coll Cardiol,2007,50(10):933-939.

[22]Ino Y,Kubo T,Tanaka A,et al.Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study[J].JACC Cardiovasc Interv,2011,4(1):76-82.

[23]Lee T,Murai T,Yonetsu T,et al.Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention[J].Circ Cardiovasc Interv,2015,8(4).doi:10.1161/CIRCINTERVENTIONS.114.001727.

[24]Nakamura S,Inami S,Murai K,et al.Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease:an optical coherence tomography study[J].Clin Res Cardiol,2014,103(12):1015-1021.

[25]Dai J,Tian J,Hou J,et al.Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome:An optical coherence tomography study[J].Atherosclerosis,2016,247:111-117.

[26]D'Ascenzo F,Barbero U,Cerrato E,et al.Accuracy of intravascular ultrasound and optical coherence tomography in identifying functionally significant coronary stenosis according to vessel diameter:A meta-analysis of 2,581 patients and 2,807 lesions[J].Am Heart J,2015,169(5):663-673.

[27]Habara M,Nasu K,Terashima M,et al.Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance[J].Circ Cardiovasc Interv,2012,5(2):193-201.

[28]Maehara A,Ben-Yehuda O,Ali Z,et al.Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound:The ILUMIEN II Study(Observational Study of Optical Coherence Tomography[OCT]in Patients Undergoing Fractional Flow Reserve [FFR]and Percutaneous Coronary Intervention)[J].JACC Cardiovasc Interv,2015,8(13):1704-1714.

[29]Wijns W,Shite J,Jones MR,et al.Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making:ILUMIEN I study[J].Eur Heart J,2015,36(47):3346-3355.

[30]Kolh P,Windecker S,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:the Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery (EACTS).Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur J Cardiothorac Surg,2014,46(4):517-592.

[31]Bech GJ,De Bruyne B,Pijls NH,et al.Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis:a randomized trial[J].Circulation,2001,103(24):2928-2934.

[32]Ali ZA,Maehara A,Généreux P,et al.Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIEN III: OPTIMIZE PCI):a randomised controlled trial[J].The Lancet,2016,388(10060):2618-2628.

[33]Falk E,Nakano M,Bentzon JF,et al.Update on acute coronary syndromes: the pathologists' view[J].Eur Heart J,2013,34(10):719-728.

[34]Jia H,Dai J,Hou J,et al.Effective anti-thrombotic therapy without stenting:intravascular optical coherence tomography-based management in plaque erosion(the EROSION study)[J].Eur Heart J,2017,38(11):792-800.

[35]Meneveau N,Ecarnot F.Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome:Results of the Multicenter,Randomized DOCTORS Study(Does Optical Coherence Tomography Optimize Results of Stenting)[J].Circulation,2017,135(9):e142-e143.

[36]Prati F,Di Vito L,Biondi-Zoccai G,et al.Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention(CLI-OPCI)study[J].EuroIntervention,2012,8(7):823-829.

[37]Cuesta J,Rivero F,Bastante T,et al.Optical Coherence Tomography Findings in Patients With Stent Thrombosis[J].Rev Esp Cardiol(Engl Ed),2017,70(12):1050-1058.

[38]Kubo T,Imanishi T,Kitabata H,et al.Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris:a serial optical coherence tomography study[J].JACC Cardiovasc Imaging,2008,1(4):475-484.

[39]Soeda T,Uemura S,Park SJ,et al.Incidence and Clinical Significance of Poststent Optical Coherence Tomography Findings:One-Year Follow-Up Study From a Multicenter Registry[J].Circulation,2015,132(11):1020-1029.

[40]Chamie D,Bezerra HG,Attizzani GF,et al.Incidence, predictors,morphological characteristics,and clinical outcomes of stent edge dissections detected by optical coherence tomography[J].JACC Cardiovasc Interv,2013,6(8):800-813.

[41]Won H,Shin DH,Kim BK,et al.Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation[J].Int J Cardiovasc Imaging,2013,29(6):1255-1263.

[42]Finn AV,Joner M,Nakazawa G,et al.Pathological correlates of late drug-eluting stent thrombosis:strut coverage as a marker of endothelialization[J].Circulation,2007,115(18):2435-2441.

[43]Matsumoto D,Shite J,Shinke T,et al.Neointimal coverage of sirolimus-eluting stents at 6-month follow-up:evaluated by optical coherence tomography[J].Eur Heart J,2007,28(8):961-967.

[44]Jang IK,Bouma BE,Kang DH,et al.Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography:comparison with intravascular ultrasound[J].J Am Coll Cardiol,2002,39(4):604-609.

[45]Barlis P,Regar E,Serruys PW,et al.An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent:a LEADERS trial sub-study[J].Eur Heart J,2010,31(2):165-176.

[46]Guagliumi G,Costa MA,Sirbu V,et al.Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction:Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction(HORIZONS-AMI)Trial[J].Circulation,2011,123(3):274-281.

[47]Varho V,Nammas W,Kiviniemi TO,et al.Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation[J].Int J Cardiol,2017,227:194-200.

[48]Souteyrand G,Amabile N,Mangin L,et al.Mechanisms of stent thrombosis analysed by optical coherence tomography:insights from the national PESTO French registry[J].Eur Heart J,2016,37(15):1208-1216.

[49]Kolh P,Windecker S,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:the Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery (EACTS).Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur J Cardiothorac Surg,2014,46(4):517-592.

备注/Memo

备注/Memo:
收稿日期: 2017-08-25.基金项目：陕西省科技攻关项目资助（S2016YFSF0666） 通讯作者：袁铭，副教授，主要从事冠心病基础和复杂冠脉介入治疗研究 Email：yuanming@fmmu.edu.cn 作者简介：邓龙祥，硕士生 Email:578464728@qq.com 共同第一作者：刘毅，主治医师，博士 Email:liuyimeishan@hotmail.com
更新日期/Last Update: 1900-01-01